Prof. Moshe Elkabets, from the Shraga Segal Department of Microbiology, Immunology and Genetics in Beer-Sheva, Israel, will present his lab's research on head and neck cancer therapy. This includes developing an antibody to eliminate metastatic cells, predicting response to immunotherapy, creating pre-clinical models for testing new treatments, and studying combination therapies.
This dissertation demonstrates how to offer additional information to aid the decision-making process of lung cancer treatment, serving as a proof-of-concept.
